Market News

Perkin Elmer (PKI)

PerkinElmer Thursday said it posted a net profit from continuing operations of $16 million, or 14 cents per share, compared with a profit of $41.7 million, or 35 cents a share, a year ago. Revenue from continuing operations in the third quarter of 2009 was $437.1 million, a decrease of 9% as compared to the same period a year ago
Profit beats Street views.

Oct 29 · 9:13:00 PM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Allergan (AGN)

Drug company Allergen said its third-quarter earnings increased to $179 million, or 58 cents per share, from $165 million, or 54 cents per share, in the year-earlier period. The company said global sales rose 4.2 percent to $1.13 billion in the quarter, topping analysts' expectations of $1.08 billion
Results were helped by rebound in Botox sales.

Oct 29 · 1:36:00 PM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Astrazeneca PLC (AZN)

AstraZeneca said its net income increased 23 percent to $2.12 billion from $1.73 billion a year earlier. Earnings excluding restructuring and other one-time costs gained to $1.68 a share from $1.32, beating analysts' forecasts. Third-quarter sales gained 5.4 percent to $8.2 billion.
Earnings rose on Swine Flu vaccine.

Oct 29 · 11:33:00 AM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Aetna (AET)

Aetna said today that its third-quarter net income climbed 18 percent to $326.2 million, or 73 cents a share, from 277.3 or 58 cents per share. Revenue rose 9% to 8,704.4 million from 7,981.4 million.
Results beat analysts' forecasts.

Oct 29 · 11:03:00 AM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Mylan (MYL)

Mylan Laboratories said today it had a third-quarter net loss attributable to Mylan common shareholders of $40.02 million or $0.13 per share, compared to profit of $182.36 million or $0.47 per share in the same quarter last year. Total revenues for the quarter declined to $1.264 billion from $1.656 billion in the prior year quarter. .
Analysts had a consensus revenue estimate of $1.23 billion in revenue for the quarter.

Oct 29 · 9:33:00 AM · Source: Company News
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Amgen (AMGN)

A British charitable trust filed a patent infringement suit against Amgen and Wyeth on Wednesday over their blockbuster Enbrel drug, one of the world's best-selling treatments for rheumatoid arthritis.
The Mathilda and Terence Kennedy Institute of Rheumatology Trust asked a federal court in Delaware to grant royalty payments and damages from Wyeth and Amgen for infringing a patent for treating arthritis.

Oct 28 · 12:28:00 PM · Source: Reuters
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto

WellPoint Health Networks (WLP)

Wellpoint said that third quarter earnings of $730.2 million, or $1.53 a share, down from $820.7 million, or $1.60 a share, a year earlier. Revenue rose 3.1% to $15.43 billion
Company's CEO said the nation's largest health insurer by members remains confident about the outlook for the current quarter and expects net growth of more than 400,000 national members in January.

Oct 28 · 10:46:00 AM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Glaxosmithkline Plc (GSK)

Glaxosmithkline said its third quarter net income increased 30 percent to 1.34 billion pounds ($2.18 billion) from 1.03 billion pounds a year earlier. Third- quarter revenue advanced 15 percent to 6.76 billion pounds, from 5.88 billion pounds,
Revenues topped the 6.75 billion-pound analyst estimates.

Oct 28 · 10:17:00 AM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Previous · Next